By Colin Kellaher
Baxter International Inc. (BAX) Tuesday said it agreed to buy Cheetah Medical, a provider of non-invasive hemodynamic monitoring technologies, for up to $230 million.
The Deerfield, Ill., medical-products company said it will pay $190 million cash at closing, along with up to an additional $40 million based on clinical and commercial milestones.
Baxter said the acquisition accelerates its presence in the specialized patient-monitoring space with technology used to guide fluid management.
Baxter said it expects to complete the acquisition in the fourth quarter, adding that the deal will be immaterial to earnings in 2019 and 2020.
Write to Colin Kellaher at email@example.com